pharmacy

GSK Acquires Tesaro in a USD 5.1 Billion Deal

GSK Acquires Tesaro in a USD 5.1 Billion Deal

GlaxoSmithKline (NYSE: GSK) announced on Monday that it will acquire Tesaro (NASDAQ: TSRO) for USD 5.1 Billion.This marks the first big acquisition since Hal Barron, a pharma veteran and experienced scientist took on the role of chief scientific off..

CVS Reported Third Quarter Earnings

CVS Reported Third Quarter Earnings

CVS Health Corp. (NYSE: CVS) reported on Tuesday higher revenue in the third quarter, as the retail pharmacy chain grew its network and got a boost from an increase in same-store prescription volumes. The Company also said it anticipates its acquisi..

Spark Therapeutics offers to cure blindness for $850,000

Spark Therapeutics offers to cure blindness for $850,000

Spark Therapeutics Inc (NASDAQ: ONCE) Luxturna, the first gene therapy in the U.S., has been approved by the Food and Drug Administration. The gene therapy is intended to treat a rare, inherited retinal disease that could possibly cause blindness. U..

CVS-Aetna Merger and Healthcare Clinics' Future

CVS-Aetna Merger and Healthcare Clinics' Future

While investors were pitched the multiple benefits of the $69 billion CVS Health Corp (NYSE: CVS) - Aetna Inc (NYSE: AET) merger, the former pitched to its shareholders and the general public that this merger could transform the drugstores owned by ..

CVS Beats Q3 Estimates but Shares Slip

CVS Beats Q3 Estimates but Shares Slip

CVS Health Corp. (NYSE:CVS) reported its third quarter earnings and beat analysts’ estimates, but shares fell by over 3 percent early shortly after open on Monday.For the third quarter, CVS reported revenue of $46.18 billion, increasing 3.5 pe..